Drug:
Reaction: PARAESTHESIA
20250101 - 20251231
No. 4201 - 4300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 4201 | 24965575 |
BR |
73 | 1 |
Administration site warmth, Feeling hot, Injection site paraesthesia, Paraesthesia, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, SIMVASTATIN, LOSARTAN POTASSIUM, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 4202 | 24965741 |
US |
54 | 1 |
Death, Blister, Stomatitis, Decreased appetite, Palmar-plantar erythrodysaesthesia syndrome, Hypoaesthesia, Paraesthesia, Erythema, Swelling, Blister, Weight decreased, Dry mouth, Skin disorder, Dry skin, Product dose omission issue, |
||||
AXITINIB, AXITINIB, AXITINIB, AXITINIB, DULOXETINE HYDROCHLORIDE, LEVOTHYROXINE, |
||||
| 4203 | 24965854 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Coeliac disease, Condition aggravated, Confusional state, Contraindicated product administered, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Product use in unapproved indication, Psoriatic arthropathy, Rash, Rheumatic fever, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 4204 | 24966179 |
CA |
76 | 1 |
Disease progression, Paraesthesia, Pain in extremity, Cough, Arthralgia, Dyspnoea, Asthenia, Dysphagia, Anxiety, |
||||
| 4205 | 24966208 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Depression, Diarrhoea, Discomfort, Dizziness, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Memory impairment, Migraine, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse event, Hospitalisation, |
||||
ABATACEPT, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, APREMILAST, LEFLUNOMIDE, LORAZEPAM, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM, CANDESARTAN, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, CYANOCOBALAMIN, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ERENUMAB-AOOE, FOLIC ACID, ALENDRONATE SODIUM, GOLD, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LAMOTRIGINE, LANSOPRAZOLE, LISINOPRIL, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, OXYCODONE, POVIDONE-IODINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RANITIDINE, INFLIXIMAB, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, SULFASALAZINE, FISH OIL, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, METHOTREXATE, METHOTREXATE SODIUM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ERENUMAB-AOOE, CALCIUM GLUCONATE, |
||||
| 4206 | 24966514 |
US |
1 | |
Neuropathy peripheral, Hypoaesthesia, Paraesthesia, Diarrhoea, Fatigue, Product use in unapproved indication, |
||||
TRAMETINIB, |
||||
| 4207 | 24966694 |
CA |
78 | 1 |
Alanine aminotransferase increased, Arrhythmia, Aspartate aminotransferase increased, Blood creatine phosphokinase increased, Blood lactate dehydrogenase increased, Diplopia, Dyspnoea, Eye pain, Eyelid ptosis, Hepatitis, Hypoacusis, Immune-mediated myocarditis, Incontinence, Malaise, Muscular weakness, Myasthenia gravis, Myositis, Paraesthesia, Troponin increased, Hospitalisation, Adverse event, |
||||
IPILIMUMAB, NIVOLUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISOPROLOL FUMARATE, FINASTERIDE, GABAPENTIN, LORAZEPAM, NAPROXEN, NAPROXEN SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, ROSUVASTATIN, ALBUTEROL SULFATE, |
||||
| 4208 | 24966770 |
US |
71 | 2 |
Sinus congestion, Erythema, Ear infection, Calcium deficiency, Pharyngeal disorder, Bone density abnormal, Sinus disorder, Bone loss, Headache, Nasopharyngitis, Paraesthesia, Pharyngitis, |
||||
ADALIMUMAB, SULFASALAZINE, RIVAROXABAN, AMLODIPINE, THYROID, PORCINE, ZOLPIDEM TARTRATE, LOSARTAN, |
||||
| 4209 | 24966986 |
US |
||
Hypersensitivity, Feeling hot, Paraesthesia, |
||||
METHYLPREDNISOLONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, EPINEPHRINE, ADRENALINUM, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ALBUTEROL SULFATE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LIDOCAINE AND PRILOCAINE, OXYGEN, 0XYGEN, LIDOCAINE, |
||||
| 4210 | 24967157 |
CA |
54 | 2 |
Plasma cell myeloma, Neuropathy peripheral, Nervous system disorder, Paraesthesia, Hypoaesthesia, Gait disturbance, Drug tolerance, Off label use, |
||||
IXAZOMIB, IXAZOMIB, IXAZOMIB, IXAZOMIB, ACYCLOVIR, PANTOPRAZOLE, |
||||
| 4211 | 24957571 |
US |
74 | 2 |
Malaise, Headache, Abdominal pain upper, Fatigue, Paraesthesia, |
||||
DUPILUMAB, THEOPHYLLINE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION, PANCRELIPASE, NAPROXEN, NAPROXEN SODIUM, MONTELUKAST SODIUM, MONTELUKAST, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE, FAMOTIDINE, EPINEPHRINE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, DEXLANSOPRAZOLE, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BACLOFEN, AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE, AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE, CYANOCOBALAMIN, URSODIOL, URSOSIOL, TOPIRAMATE, TOPIRAMATE SPINKLE, ONDANSETRON HYDROCHLORIDE, ALBUTEROL SULFATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, PREDNISONE, AZATHIOPRINE, |
||||
| 4212 | 24957988 |
US |
72 | 2 |
Myalgia, Tendon pain, Spinal fracture, Foot fracture, Paraesthesia, Rash, Muscular weakness, Arthropathy, |
||||
OMALIZUMAB, |
||||
| 4213 | 24958047 |
CA |
64 | 2 |
Ageusia, Anosmia, Arthralgia, Conjunctivitis, Dry eye, Fatigue, Feeling abnormal, Feeling jittery, Hypersensitivity, Illness, Insomnia, Muscle tightness, Nasal polyps, Nasopharyngitis, Pain in extremity, Paraesthesia, Pruritus, Pulmonary congestion, Sinusitis, Stress, Urticaria, Product dose omission issue, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, GATIFLOXACIN, |
||||
| 4214 | 24958168 |
CA |
31 | 2 |
Erythema, Burning sensation, Decreased immune responsiveness, Face oedema, Fatigue, Feeling hot, Insomnia, Mechanical urticaria, Musculoskeletal stiffness, Oedema, Oedema peripheral, Pain, Paraesthesia, Pruritus, Road traffic accident, Scratch, Skin plaque, Stress, Swelling, Systemic lupus erythematosus, Therapeutic product effect incomplete, Urticaria, Wrong technique in product usage process, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, HYDROXYCHLOROQUINE SULFATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 4215 | 24958170 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthropathy, Asthenia, Arthralgia, Blepharospasm, Blood cholesterol increased, Blister, Bursitis, Breast cancer stage III, C-reactive protein increased, Condition aggravated, Confusional state, Depression, Decreased appetite, Diarrhoea, Dizziness, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fibromyalgia, Fatigue, Folliculitis, Gastrooesophageal reflux disease, Glossodynia, General physical health deterioration, Hand deformity, Headache, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Impaired healing, Hypocholesterolaemia, Inflammation, Irritable bowel syndrome, Infusion related reaction, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver injury, Lung disorder, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Obesity, Night sweats, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Vomiting, Urticaria, Weight increased, Wheezing, Wound, Contraindicated product administered, Maternal exposure during pregnancy, Exposure during pregnancy, Product quality issue, Wound infection, Helicobacter infection, Lower respiratory tract infection, Type 2 diabetes mellitus, |
||||
SARILUMAB, |
||||
| 4216 | 24958576 |
CA |
53 | 2 |
Angina pectoris, Erythema, Nausea, Paraesthesia, Pruritus, Quality of life decreased, Stress, Urticaria, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, |
||||
| 4217 | 24958716 |
CH |
53 | 1 |
Polyneuropathy, Condition aggravated, Paraesthesia, Hand dermatitis, Neurological symptom, Peripheral motor neuropathy, Psoriasis, |
||||
DUPILUMAB, MONTELUKAST, FLUTICASONE FUROATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 4218 | 24959172 |
CA |
29 | 2 |
Abdominal pain upper, Acne, Fatigue, Angioedema, Cellulitis, Chills, Cough, Eye irritation, Eye oedema, Eye pain, Eye pruritus, Eye swelling, Hormone level abnormal, Hot flush, Night sweats, Oropharyngeal pain, Pain, Paraesthesia, Paraesthesia oral, Paranasal sinus hypersecretion, Pruritus, Rhinorrhoea, Seasonal allergy, Sinus congestion, Swelling, Swelling of eyelid, Urticaria, Weight increased, Product availability issue, Therapeutic response shortened, Inappropriate schedule of product administration, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, |
||||
| 4219 | 24959219 |
CA |
44 | 2 |
Abdominal pain upper, Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Chest pain, Colitis ulcerative, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Facet joint syndrome, Fatigue, Feeling hot, Fibromyalgia, Folliculitis, Frequent bowel movements, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Hypertension, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver disorder, Lower respiratory tract infection, Lung disorder, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Obesity, Oedema, Oedema peripheral, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Porphyria acute, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rectal haemorrhage, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, |
||||
INDOMETHACIN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PREDNISONE, PREDNISONE, APREPITANT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, SULFASALAZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, LEFLUNOMIDE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SECUKINUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, RITUXIMAB-ABBS, RITUXIMAB-ABBS, ERGOCALCIFEROL, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, FISH OIL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CALCIUM GLUCONATE, ERGOCALCIFEROL, QUETIAPINE FUMARATE, QUETIAPINE, LANSOPRAZOLE, |
||||
| 4220 | 24959553 |
NL |
70 | 1 |
Myalgia, Deafness, Paraesthesia, Fatigue, Asthenia, Depressed mood, Hot flush, Pruritus, Ear pruritus, |
||||
EZETIMIBE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, HYDROCHLOROTHIAZIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 4221 | 24959785 |
CA |
40 | 2 |
Peripheral swelling, Abdominal discomfort, Abdominal distension, Abdominal pain upper, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Confusional state, Condition aggravated, Contusion, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscle spasms, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Live birth, Urticaria, Paraesthesia, Peripheral swelling, Peripheral venous disease, Rheumatic fever, Sleep disorder, Stomatitis, Taste disorder, Infusion related reaction, Underdose, Off label use, Maternal exposure during pregnancy, Treatment failure, Intentional product use issue, Exposure during pregnancy, Drug intolerance, Drug ineffective, Contraindicated product administered, Product quality issue, Therapeutic product effect decreased, Therapeutic product effect incomplete, Lower respiratory tract infection, Helicobacter infection, Decreased appetite, Type 2 diabetes mellitus, Urticaria, Weight increased, Wheezing, Wound infection, |
||||
SARILUMAB, |
||||
| 4222 | 24960466 |
HR |
70 | 2 |
Neuropathy peripheral, Oral discomfort, Paraesthesia, |
||||
PREGABALIN, |
||||
| 4223 | 24960966 |
CA |
40 | 2 |
Decreased appetite, Hypersensitivity, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Off label use, Onychomadesis, Onychomycosis, Osteoarthritis, Overdose, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Product use in unapproved indication, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Underdose, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, TRAMADOL HYDROCHLORIDE, ERENUMAB-AOOE, APREMILAST, APREMILAST, CELECOXIB, CELECOXIB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, GOLIMUMAB, GOLIMUMAB, AZATHIOPRINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RAMIPRIL, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 4224 | 24960972 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Contraindicated product administered, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Exposure during pregnancy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Off label use, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Loss of personal independence in daily activities, Product label confusion, Product quality issue, Product use in unapproved indication, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, |
||||
BUPRENORPHINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, TRAMADOL HYDROCHLORIDE, DICLOFENAC, DICLOFENAC SODIUM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ADALIMUMAB, ADALIMUMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, NAPROXEN, NAPROXEN SODIUM, |
||||
| 4225 | 24961060 |
CA |
50 | 2 |
Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bursitis, C-reactive protein, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hip arthroplasty, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Knee arthroplasty, Lip dry, Liver disorder, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Night sweats, Obesity, Oedema, Off label use, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pregnancy, Prescribed overdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Sinusitis, Sleep disorder due to general medical condition, hypersomnia type, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Tender joint count, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, |
||||
SARILUMAB, |
||||
| 4226 | 24961138 |
CA |
43 | 2 |
Breast cancer stage III, Liver injury, Duodenal ulcer perforation, Epilepsy, Hand deformity, Lower respiratory tract infection, Psoriatic arthropathy, Pemphigus, Pericarditis, Rheumatoid arthritis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Abdominal pain upper, Condition aggravated, C-reactive protein increased, Blood cholesterol increased, Confusional state, Blister, Blepharospasm, Asthenia, Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Bursitis, Decreased appetite, Depression, Diarrhoea, Dizziness, Dry mouth, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Headache, Helicobacter infection, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Hypocholesterolaemia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Lung disorder, Memory impairment, Migraine, Mobility decreased, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain, Paraesthesia, Peripheral swelling, Peripheral venous disease, Rash, Stomatitis, Swelling, Synovitis, Taste disorder, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Contraindicated product administered, Maternal exposure during pregnancy, Exposure during pregnancy, Product quality issue, |
||||
MIRABEGRON, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, RITUXIMAB, RITUXIMAB, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, HYDROXYCHLOROQUINE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, LEFLUNOMIDE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 4227 | 24961409 |
PT |
70 | 2 |
Paraesthesia, |
||||
CANAGLIFLOZIN, |
||||
| 4228 | 24961891 |
61 | 2 | |
Chest discomfort, Mouth swelling, Pharyngeal swelling, Hypersensitivity, Tremor, Asthenia, Dysphagia, Weight decreased, Hypophagia, Paraesthesia, Vision blurred, |
||||
ONABOTULINUMTOXINA, SERTRALINE, |
||||
| 4229 | 24962121 |
IL |
28 | 2 |
Suffocation feeling, Malaise, Tremor, Paraesthesia, Swelling face, Heart rate increased, |
||||
ENOXAPARIN SODIUM, |
||||
| 4230 | 24962382 |
US |
46 | 2 |
Vision blurred, Ear pain, Tinnitus, Pain in extremity, Paraesthesia, Injection site pain, Neck pain, Muscle spasms, Headache, Pyrexia, Vomiting, |
||||
IOHEXOL, IOHEXOL, INFLIXIMAB, |
||||
| 4231 | 24962419 |
CA |
43 | 2 |
Adjustment disorder with depressed mood, Abdominal discomfort, Abdominal pain, Abdominal pain upper, Adverse drug reaction, Adverse event, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back disorder, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage II, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Fluid retention, Folliculitis, Gait disturbance, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, General symptom, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Knee arthroplasty, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Myositis, Nail disorder, Nasopharyngitis, Nausea, Night sweats, Obesity, Oedema, Oedema peripheral, Off label use, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product quality issue, Product use in unapproved indication, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sleep disorder, Sleep disorder due to a general medical condition, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Walking aid user, Weight decreased, Weight increased, Wheezing, Wound infection, Wound, X-ray abnormal, Sinusitis, Bone erosion, Deep vein thrombosis postoperative, No adverse event, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, BUPRENORPHINE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN AND CODEINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLD, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CALCIUM CARBONATE, USTEKINUMAB, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, BOTULINUM TOXIN TYPE A, CANDESARTAN, CELECOXIB, CELECOXIB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, VEDOLIZUMAB, NAPROXEN, NAPROXEN SODIUM, ERENUMAB-AOOE, ATOMOXETINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SECUKINUMAB, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, PHENYLEPHRINE HYDROCHLORIDE, APREMILAST, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, LORAZEPAM, CALCIUM, CALCIUM, CALCIUM, CAFFEINE CITRATE, CYANOCOBALAMIN, ERGOCALCIFEROL, ASIAN GINSENG, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, LANSOPRAZOLE, LORAZEPAM, NICOTINAMIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, LANSOPRAZOLE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RISEDRONATE SODIUM, THIAMINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN A, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ERGOCALCIFEROL, LISINOPRIL, FISH OIL, SULFASALAZINE, |
||||
| 4232 | 24962437 |
US |
62 | 2 |
Hypoaesthesia, Vision blurred, Peripheral swelling, Paraesthesia, Palpitations, |
||||
| 4233 | 24962662 |
US |
59 | 1 |
Pain, Hypoaesthesia, Paraesthesia, |
||||
LENALIDOMIDE, |
||||
| 4234 | 24964870 |
84 | 2 | |
Paraesthesia, Hypoaesthesia, Balance disorder, Blood glucose abnormal, Appetite disorder, Therapy cessation, |
||||
POMALIDOMIDE, |
||||
| 4235 | 24952734 |
CA |
27 | 2 |
Pyrexia, Concussion, Cough, Discomfort, Fatigue, Head injury, Headache, Hypoaesthesia, Loss of consciousness, Mania, Nasal congestion, Nasopharyngitis, Nausea, Oropharyngeal pain, Pain, Pain in extremity, Paraesthesia, Circumstance or information capable of leading to medication error, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETINE, METHYLPHENIDATE HYDROCHLORIDE, LEMBOREXANT, ADALIMUMAB-FKJP, ADALIMUMAB-FKJP, ADALIMUMAB-FKJP, ADALIMUMAB-FKJP, QUETIAPINE, |
||||
| 4236 | 24952994 |
ES |
61 | 2 |
Dyspnoea, Paraesthesia, Tachycardia, |
||||
AZELASTINE HYDROCHLORIDE, AZELASTINE, |
||||
| 4237 | 24953365 |
US |
37 | 2 |
Neuropathy peripheral, Multiple sclerosis relapse, Muscle spasms, Musculoskeletal stiffness, Paraesthesia, Influenza like illness, Pain, Hyperhidrosis, Chills, Cough, Pyrexia, Hypoaesthesia, Anaesthesia, Pain in extremity, |
||||
OFATUMUMAB, OFATUMUMAB, BACLOFEN, LEVOCETIRIZINE DIHYDROCHLORIDE, PHENAZOPYRIDINE, GABAPENTIN, |
||||
| 4238 | 24953385 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Normal newborn, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, |
||||
SARILUMAB, |
||||
| 4239 | 24953421 |
CA |
54 | 1 |
Abdominal hernia, Asthma, Blood pressure increased, Blood urine present, Chest pain, Chronic pigmented purpura, Decreased activity, Diverticulitis, Drug hypersensitivity, Dyspnoea, Fatigue, Gastroenteritis, Headache, Hiatus hernia, Illness, Infection, Influenza, Inguinal hernia, Middle insomnia, Paraesthesia, Pharyngitis, Pneumonia, Productive cough, Pyrexia, Sinonasal obstruction, Sinus polyp, Sputum discoloured, Subcutaneous abscess, Tachycardia, Thyroid mass, Wheezing, Incorrect dose administered, Wrong technique in product usage process, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CARBAMAZEPINE, CARBAMAZEPINE, VALSARTAN, VALSARTAN ORAL, ARIPIPRAZOLE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CICLESONIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, LORATADINE, LORATADINE TABLET, IRON, MOMETASONE FUROATE, MOMETASONE, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, OXAZEPAM, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, ALBUTEROL SULFATE, ALBUTEROL, SILDENAFIL CITRATE, SILDENAFIL, SULFASALAZINE, TERBUTALINE SULFATE, TOPIRAMATE, TOPIRAMATE SPINKLE, ALBUTEROL SULFATE, AZITHROMYCIN DIHYDRATE, |
||||
| 4240 | 24953712 |
CA |
55 | 2 |
Acne, Blood pressure systolic increased, Concomitant disease aggravated, Dermal cyst, Erythema, Eye pain, Feeling hot, Haemorrhage urinary tract, Headache, Insomnia, Livedo reticularis, Major depression, Mental fatigue, Oxygen saturation decreased, Paraesthesia, Pruritus, Rash, Scratch, Skin burning sensation, Skin irritation, Skin plaque, Skin swelling, Stress, Suicidal ideation, Urinary tract infection, Urticaria, Weight decreased, Product dose omission issue, Inappropriate schedule of product administration, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CICLESONIDE, DIPHENHYDRAMINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONIDINE, DEXLANSOPRAZOLE, LORAZEPAM, MONTELUKAST, NABILONE, OXAZEPAM, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, |
||||
| 4241 | 24953716 |
US |
64 | 1 |
Paraesthesia, |
||||
ERENUMAB-AOOE, PREGABALIN, TOPIRAMATE, |
||||
| 4242 | 24953851 |
ES |
||
Dyspnoea, Tachycardia, Paraesthesia, |
||||
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, AZELASTINE, |
||||
| 4243 | 24954002 |
SE |
68 | 2 |
Blindness, Visual impairment, Paraesthesia, Neuralgia, Chest pain, Ophthalmic migraine, Insomnia, Nausea, Dizziness, Cough, Hypotension, Muscle spasms, Fall, Limb injury, Headache, Peripheral coldness, Hypoaesthesia, Eye pain, |
||||
METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, |
||||
| 4244 | 24954183 |
ZA |
52 | 2 |
Sinusitis, Multiple sclerosis, Visual impairment, Paraesthesia, Sensory loss, Drug ineffective, Therapeutic response shortened, |
||||
OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, FINGOLIMOD HYDROCHLORIDE, |
||||
| 4245 | 24954459 |
GB |
54 | 2 |
Drug reaction with eosinophilia and systemic symptoms, Autonomic nervous system imbalance, Amnesia, Hypertension, Haematoma, Musculoskeletal stiffness, Vibration syndrome, Muscle spasms, Postural orthostatic tachycardia syndrome, Internal haemorrhage, Chest discomfort, Angina pectoris, Sleep apnoea syndrome, Confusional state, Pain, Pyrexia, Hot flush, Dizziness, Blood pressure diastolic, Fatigue, Chest pain, Dizziness postural, Vertigo, Ear pain, Vision blurred, Vessel puncture site bruise, Photophobia, Parosmia, Paraesthesia, Hypoaesthesia, Limb discomfort, Burning sensation, Palpitations, Chills, Decreased appetite, Weight decreased, Dyspepsia, Exercise tolerance decreased, Pollakiuria, Varicose vein, Anxiety, Malaise, Pain in extremity, Nausea, Headache, Injection site bruising, Peripheral swelling, Feeling hot, Injection site indentation, Injection site swelling, Costochondritis, |
||||
IRON, |
||||
| 4246 | 24955428 |
CA |
27 | 1 |
Colitis ulcerative, Abscess, Pneumonia, Peripheral swelling, Psoriasis, Subcutaneous abscess, Back injury, Off label use, Vomiting, Anal fissure, Hypoaesthesia, Intervertebral disc protrusion, Joint swelling, Diarrhoea, Abdominal pain upper, Chest pain, Abdominal pain, Chest discomfort, Paraesthesia, Chills, Headache, Back pain, Nausea, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, PREDNISONE, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 4247 | 24955562 |
US |
28 | 1 |
Dyspnoea, Paraesthesia, Oesophageal discomfort, Cyanosis, Tremor, Chest pain, |
||||
DUPILUMAB, |
||||
| 4248 | 24955646 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Depression, Diarrhoea, Discomfort, Dizziness, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme abnormal, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Memory impairment, Migraine, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse event, Hospitalisation, |
||||
ABATACEPT, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, APREMILAST, LEFLUNOMIDE, LORAZEPAM, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM, CANDESARTAN, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, CYANOCOBALAMIN, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, FOLIC ACID, ALENDRONATE SODIUM, GOLD, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LAMOTRIGINE, LANSOPRAZOLE, LISINOPRIL, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, OXYCODONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RANITIDINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, SULFASALAZINE, FISH OIL, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, |
||||
| 4249 | 24955650 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Depression, Diarrhoea, Discomfort, Dizziness, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Memory impairment, Migraine, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse event, |
||||
ABATACEPT, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, APREMILAST, LEFLUNOMIDE, LORAZEPAM, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM, CANDESARTAN, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, CYANOCOBALAMIN, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, FOLIC ACID, ALENDRONATE SODIUM, GOLD, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IODINE, LAMOTRIGINE, LANSOPRAZOLE, LISINOPRIL, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, OXYCODONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RANITIDINE, INFLIXIMAB, RISEDRONATE SODIUM, RITUXIMAB, SULFASALAZINE, FISH OIL, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, |
||||
| 4250 | 24955978 |
GB |
53 | 2 |
Paraesthesia, Paraesthesia oral, Hypoaesthesia oral, Hypoaesthesia, Anal hypoaesthesia, Hypoaesthesia, Immobile, Tongue coated, Medication error, Vision blurred, |
||||
| 4251 | 24955997 |
US |
70 | 1 |
Sleep disorder due to a general medical condition, Hypoaesthesia, Paraesthesia, Pain in extremity, |
||||
DUPILUMAB, |
||||
| 4252 | 24956210 |
US |
41 | 1 |
Paraesthesia, Paraesthesia, Urticaria, Sinus congestion, Headache, Mechanical urticaria, |
||||
OMALIZUMAB, |
||||
| 4253 | 24956214 |
CA |
||
Agitation, Anxiety, Extrasystoles, Palpitations, Panic attack, Paraesthesia, Peripheral swelling, Pruritus, |
||||
FAMOTIDINE, |
||||
| 4254 | 24956335 |
CA |
44 | 2 |
Anxiety, Arthropod bite, Barrett^s oesophagus, Blood pressure decreased, Blood pressure decreased, Body temperature increased, Chest pain, Dizziness, Drug hypersensitivity, Drug hypersensitivity, Dysphagia, Dyspnoea, Dyspnoea, Ear swelling, Eye swelling, Fatigue, Feeling hot, Haemorrhage, Headache, Heart rate increased, Hyperhidrosis, Hypoaesthesia, Hypotension, Illness, Incorrect dose administered, Insomnia, Laryngitis, Middle insomnia, Nasopharyngitis, Oropharyngeal pain, Pain, Palpitations, Panic reaction, Papule, Paraesthesia, Peripheral swelling, Pneumonia, Pruritus, Pulmonary embolism, Rash, Rash erythematous, Scratch, Sensitivity to weather change, Skin lesion, Skin mass, Skin plaque, Swelling, Swollen tongue, Throat tightness, Urinary tract infection, Urticaria, Weight increased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CYCLOSPORINE, APIXABAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CYCLOBENZAPRINE, EPINEPHRINE, FAMOTIDINE, FERROUS SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYZINE, LANSOPRAZOLE, LANSOPRAZOLE, MONTELUKAST, PANTOPRAZOLE, PREGABALIN, MONTELUKAST SODIUM, |
||||
| 4255 | 24956676 |
GB |
64 | 2 |
Visual impairment, Paraesthesia, Migraine, |
||||
ATOGEPANT, PREGABALIN, PROPRANOLOL HYDROCHLORIDE, MELATONIN, |
||||
| 4256 | 24956682 |
EU |
62 | 1 |
Motor dysfunction, Condition aggravated, Ischaemic stroke, Dysarthria, Paraesthesia, Drug ineffective, |
||||
OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ENOXAPARIN SODIUM, ENOXAPARIN SODIUM, ENOXAPARIN SODIUM, ENOXAPARIN SODIUM, APIXABAN, APIXABAN, APIXABAN, APIXABAN, |
||||
| 4257 | 24956728 |
CA |
43 | 2 |
Wound infection, Stomatitis, Sleep disorder, Rheumatoid arthritis, Product use in unapproved indication, Product quality issue, Pneumonia, Peripheral venous disease, Peripheral swelling, Pemphigus, Paraesthesia, Wheezing, Osteoarthritis, Onychomadesis, Obesity, Night sweats, Neck pain, Nasopharyngitis, Muscular weakness, Muscle spasms, Muscle injury, Lung disorder, Urticaria, Liver function test increased, Irritable bowel syndrome, Intentional product use issue, Infusion site reaction, Infusion related reaction, Impaired healing, Hypoaesthesia, Hypertension, Hypercholesterolaemia, Hepatic enzyme increased, Type 2 diabetes mellitus, Helicobacter infection, Glossodynia, General physical health deterioration, Gastrooesophageal reflux disease, Gait inability, Folliculitis, Fibromyalgia, Facet joint syndrome, Epilepsy, Duodenal ulcer perforation, Treatment failure, Dry mouth, Drug intolerance, Drug hypersensitivity, Dizziness, Depression, Contraindicated product administered, Confusional state, Therapeutic product effect decreased, Taste disorder, Systemic lupus erythematosus, Synovitis, |
||||
CANDESARTAN, CANDESARTAN, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, OXYCODONE, RITUXIMAB, |
||||
| 4258 | 24956771 |
US |
63 | 2 |
Pneumonia, Herpes zoster, Paraesthesia, Neuropathy peripheral, COVID-19, |
||||
TOFACITINIB, PROPYLENE GLYCOL, PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION, CALCIUM, BLACK COHOSH, BRYONIA ALBA WHOLE, TOXICODENDRON PUBESCENS WHOLE, ARNICA MONTANA, CAUSTICUM, FERROSOFERRIC PHOSPHATE, SODIUM SULFATE ANHYDROUS, STRYCHNOS NUX-VOMICA SEED, RHODODENDRON AUREUM WHOLE, CITRULLUS COLOCYNTHIS WHOLE, SOLANUM DULCAMARA WHOLE, KALMIA LATIFOLIA WHOLE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, ARSENIC TRIOXIDE, AND TRIBASIC CALCIUM PHOSPHATE, BERBERIS VULGARIS ROOT BARK, BRYONIA ALBA ROOT, PHENOL, MILK THISTLE, CHELIDONIUM MAJUS, JUNIPER BERRY, LYCOPODIUM CLAVATUM SPORE, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE, SODIUM SULFATE, STRYCHNOS NUX-VOMICA SEED, PHOSPHORUS, LACTIC ACID, L-, TARAXACUM OFFICINALE, VISCUM ALBUM FRUITING TOP, AND YUCCA FILAMENTOSA, ARTEMISIA CINA PRE-FLOWERING TOP, TANACETUM VULGARE WHOLE, ARTEMISIA VULGARIS WHOLE, DRYOPTERIS FILIX-MAS ROOT, MERCURIC CHLORIDE, AND GRAPHITE, AMBROSIA ARTEMISIAEFOLIA, ARALIA RACEMOSA, ARNICA MONTANA, CALENDULA OFFICINALIS, CHROMICUM ACIDUM, ECHINACEA PURPUREA, EUCALYPTOL, KALI BICHROMICUM, KALI MURIATICUM, KALI SULPHURICUM, LAC VACCINUM, MERCURIUS IODATUS FLAVUS, MERCURIUS SULPHURATUS RUBER, NATRUM ARSENICICUM, ROSA DAMASCENA, SABADILLA, SANGUINARINUM NITRICUM, SYMPHYTUM OFFICINALE, NAJA NAJA WHOLE, SCROPHULARIA NODOSA, LACTIC ACID, DL-, AND RADIUM BROMIDE, APIS MELLIFERA, ASPARAGUS, BERBERIS VULGARIS ROOT BARK, LYTTA VESICATORIA, CHELIDONIUM MAJUS, JUNIPER BERRY, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, POPULUS TREMULOIDES BARK, RHUS AROMATICA ROOT BARK, RUBIA TINCTORUM ROOT, SAW PALMETTO, SOLIDAGO VIRGAUREA FLOWERING TOP, TARAXACUM OFFICINALE, AND ARCTOSTAPHYLOS UVA-URSI LEAF, AVENA SATIVA WHOLE, VALERIANA OFFICINALIS WHOLE, HUMULUS LUPULUS WHOLE, ARABICA COFFEE BEAN, STRYCHNOS IGNATII WHOLE, ZINC VALERATE DIHYDRATE, AMMONIUM BROMIDE, CHAMOMILE, ESCHSCHOLZIA CALIFORNICA, AND PASSIFLORA INCARNATA WHOLE, APIS MELLIFICA, ARGENTUM NITRICUM, BADIAGA, BELLADONNA, CANTHARIS, CAUSTICUM, CHIMAPHILA UMBELLATA, COLOCYNTHIS, CUBEBA OFFICINALIS, CUCURBITA CITRULLUS, CUCURBITA PEPO FLOWER, ECHINACEA ANGUSTIFOLIA, EQUISETUM HYEMALE, ERYNGIUM AQUATICUM, FERRUM PHOSPHORICUM, MITCHELLA REPENS, OLEUM SANTALI, PETROSELINUM SATIVUM, PIPER METHYSTICUM, POPULUS TREMULOIDES BARK, SARSAPARILLA, TEREBINTHINA, UVA URSI, ACHILLEA MILLEFOLIUM, ARNICA MONTANA, HYPERICUM PERFORATUM, HORSE CHESTNUT, AND VISCUM ALBUM WHOLE, ACONITUM NAPELLUS, AMERICAN GINSENG, ARSENICUM IODATUM, BLATTA ORIENTALIS, CALCAREA SULPHURICA, CARPINUS BETULUS FLOWER, CUPRUM METALLICUM, GRINDELIA, HEPAR SULPHURIS CALCAREUM, IPECACUANHA, JUSTICIA ADHATODA, KALI IODATUM, LOBELIA INFLATA, NAPHTHALINUM, NARCISSUS PSEUDONARCISSUS, PINE TAR, POPULUS CANDICANS, TABACUM, THUJA OCCIDENTALIS, THYMUS SERPYLLUM, PASSIFLORA INCARNATA WHOLE, SMILAX ORNATA WHOLE, PHYTOLACCA AMERICANA ROOT, STILLINGIA SYLVATICA ROOT, TRIFOLIUM PRATENSE WHOLE, ARCTIUM LAPPA WHOLE, PRUNUS DULCIS WHOLE, FRANGULA PURSHIANA BARK, BERBERIS VULGARIS WHOLE, GLYCYRRHIZA GLABRA WHOLE, AND LARREA DIVARICATA WHOLE, ALOE, ACTIVATED CHARCOAL, COLCHICUM AUTUMNALE BULB, COLLINSONIA CANADENSIS ROOT, CUCURBITA PEPO FLOWER, DRYOPTERIS FILIX-MAS ROOT, INDOLE, SKIM MILK, LYCOPODIUM CLAVATUM SPORE, ACHILLEA MILLEFOLIUM, SODIUM SULFATE, FRANGULA PURSHIANA BARK, SCROPHULARIA NODOSA, SKATOLE, TARAXACUM OFFICINALE, TARTARIC ACID, ARANEUS DIADEMATUS, ARISAEMA TRIPHYLLUM ROOT, ASTERIAS RUBENS, BAPTISIA TINCTORIA, BARIUM IODIDE, ECHINACEA ANGUSTIFOLIA, FERROUS IODIDE, GOLDENSEAL, LACHESIS MUTA VENOM, PHYTOLACCA AMERICANA ROOT, PINUS SYLVESTRIS FLOWERING TOP, SCROPHULARIA NODOSA, SPONGIA OFFICINALIS SKELETON, ROASTED, AND TEUCRIUM SCORODONIA FLOWERING TOP, ALFALFA, ALLIUM SATIVUM, ASPARAGUS OFFICINALIS, AVENA SATIVA, BELLADONNA, BERBERIS VULGARIS, CHELIDONIUM MAJUS, GLYCYRRHIZA GLABRA, HYDRASTIS CANADENSIS, JUNIPERUS VIRGINIANA, NICCOLUM METALLICUM, PASSIFLORA INCARNATA, SARCOLACTICUM ACIDUM, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE, ALNUS GLUTINOSA, APIS MELLIFICA, BERBERIS VULGARIS, CALCIUM SULFIDE, CROTON TIGLIUM, ECHINACEA ANGUSTIFOLIA, GRAPHITE, GRINDELIA HIRSUTULA, HYDROFLUORIC ACID, JUGLANS REGIA, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, MYRISTICA SEBIFERA, NITRICUM ACIDUM, PHOSPHORUS, RHUS TOXICODENDRON, SCROPHULARIA NODOSA, SOLIDAGO VIRGAUREA, SULPHUR, VINCA MINOR, ZINC GLUCONATE, BIOTIN, ACETAMINOPHEN, |
||||
| 4259 | 24956878 |
US |
69 | 1 |
Paraesthesia, |
||||
LENALIDOMIDE, |
||||
| 4260 | 24957407 |
US |
58 | 1 |
Hypoaesthesia, Paraesthesia, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 4261 | 24960952 |
23 | 2 | |
Chest pain, Middle insomnia, Arthralgia, Hyperhidrosis, Paraesthesia, |
||||
OMALIZUMAB, |
||||
| 4262 | 24946313 |
GB |
68 | 2 |
Paraesthesia, |
||||
THEOPHYLLINE ANHYDROUS, THEOPHYLLINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, ALBUTEROL SULFATE, ALBUTEROL, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 4263 | 24946349 |
CA |
43 | 2 |
Type 2 diabetes mellitus, Pemphigus, Paraesthesia, Rheumatoid arthritis, Product use in unapproved indication, Condition aggravated, Nasopharyngitis, Peripheral venous disease, Nail disorder, Muscle spasms, Synovitis, Night sweats, Joint swelling, Obesity, Off label use, Wound, Product quality issue, Migraine, Drug ineffective, Pain, Taste disorder, Ulcer haemorrhage, Therapeutic product effect decreased, Therapeutic product effect incomplete, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERENUMAB-AOOE, ERENUMAB-AOOE, RITUXIMAB, SARILUMAB, SARILUMAB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, APREMILAST, APREMILAST, BUPRENORPHINE, CELECOXIB, CELECOXIB, CELECOXIB, CYCLOBENZAPRINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, ERENUMAB-AOOE, HYDROMORPHONE HYDROCHLORIDE, |
||||
| 4264 | 24946393 |
CA |
40 | 2 |
Pneumonia, Adverse reaction, Contraindicated product administered, Obesity, Onychomycosis, Hepatic enzyme increased, Blepharospasm, Discomfort, Glossodynia, Peripheral venous disease, Asthenia, Breast cancer stage III, Fibromyalgia, Abdominal pain upper, Facet joint syndrome, Headache, Peripheral swelling, Dizziness, Hepatic enzyme, Off label use, Helicobacter infection, Urticaria, Gastrointestinal disorder, Wheezing, C-reactive protein increased, Drug ineffective, Product use in unapproved indication, Depression, Injection site reaction, Confusional state, Dry mouth, Coeliac disease, Weight increased, Vomiting, Hand deformity, Onychomadesis, Osteoarthritis, Paraesthesia, General physical health deterioration, Epilepsy, Blister, Grip strength decreased, Folliculitis, Wound, Product quality issue, Duodenal ulcer perforation, Taste disorder, Gait inability, Sleep disorder, Drug intolerance, Drug hypersensitivity, Wound infection, Swelling, Abdominal pain, Nasopharyngitis, Nail disorder, Musculoskeletal pain, Muscle spasms, Muscle injury, Migraine, Memory impairment, Lung disorder, Lower respiratory tract infection, Liver injury, Lip dry, Joint swelling, Joint range of motion decreased, Intentional product use issue, Type 2 diabetes mellitus, Systemic lupus erythematosus, Synovitis, Stomatitis, Rheumatoid arthritis, Rash, Psoriatic arthropathy, Pericarditis, Pemphigus, Pain, Night sweats, Insomnia, Irritable bowel syndrome, Injury, Infusion related reaction, Impaired healing, Hypoaesthesia, Hypertension, Hypercholesterolaemia, Hepatitis, Gastrooesophageal reflux disease, Finger deformity, Fatigue, Fall, Dyspepsia, Drug-induced liver injury, Diarrhoea, Condition aggravated, Bursitis, Blood cholesterol increased, Back injury, Arthropathy, Arthralgia, Anti-cyclic citrullinated peptide antibody positive, Alopecia, Abdominal discomfort, Abdominal distension, Inflammation, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CANDESARTAN, SECUKINUMAB, OXYCODONE, OXYCODONE, ETANERCEPT, ERENUMAB-AOOE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, SECUKINUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, MINOCYCLINE, MINOCYCLINE, MINOCYCLINE, SARILUMAB, NICOTINAMIDE, NICOTINAMIDE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, MIRABEGRON, MIRABEGRON, MIRABEGRON, MIRABEGRON, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, RANITIDINE, RANITIDINE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, APREMILAST, AZATHIOPRINE, AZATHIOPRINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, GOLD, HYDROCORTISONE BUTYRATE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, BUPRENORPHINE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, TOFACITINIB, ACETAMINOPHEN AND CODEINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ATOMOXETINE, ATOMOXETINE, ATOMOXETINE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CALCIUM CARBONATE, |
||||
| 4265 | 24946453 |
US |
31 | 2 |
Paraesthesia, Eye irritation, Ocular hyperaemia, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 4266 | 24946502 |
US |
60 | 2 |
Intervertebral disc compression, Exostosis, Osteoarthritis, Hypoaesthesia, Paraesthesia, Intervertebral disc degeneration, Nerve compression, Musculoskeletal disorder, Arthritis, |
||||
ADALIMUMAB, |
||||
| 4267 | 24946651 |
US |
54 | 2 |
Post transplant lymphoproliferative disorder, Abscess, Tremor, Paraesthesia, Hepatic artery stenosis, Biliary obstruction, Biloma, |
||||
CYCLOSPORINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, BASILIXIMAB, |
||||
| 4268 | 24946804 |
GB |
67 | 2 |
Palmar-plantar erythrodysaesthesia syndrome, Skin exfoliation, Pain in extremity, Burning sensation, Paraesthesia, Erythema, Tenderness, Pain, |
||||
CAPECITABINE, BISOPROLOL FUMARATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, SIMVASTATIN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 4269 | 24946887 |
DE |
46 | 1 |
COVID-19, Suicidal ideation, Asthenia, Gait disturbance, Off label use, Myalgia, Muscle tightness, Electric shock sensation, Musculoskeletal pain, Dysstasia, Sciatica, Arthralgia, Erectile dysfunction, Dry mouth, Insomnia, Fine motor skill dysfunction, Paraesthesia, Blood pressure increased, Heart rate increased, Abdominal pain, Emotional distress, Hypokinesia, Depression, Hypertension, Nightmare, Night sweats, Acne, Myalgia, Dyspnoea, Peroneal nerve palsy, Drug ineffective, Fall, Blood glucose increased, Tremor, |
||||
OCRELIZUMAB, TIZANIDINE, DALFAMPRIDINE, |
||||
| 4270 | 24947424 |
CA |
43 | 2 |
Exposure during pregnancy, Synovitis, Paraesthesia, Impaired healing, Joint swelling, Arthralgia, Muscle spasms, Pain, Infusion related reaction, Gastrooesophageal reflux disease, Hypocholesterolaemia, Irritable bowel syndrome, Headache, Hepatic enzyme increased, Peripheral swelling, Blepharospasm, Depression, Memory impairment, Peripheral venous disease, Weight increased, Wound, Joint range of motion decreased, Folliculitis, Night sweats, Dizziness, Taste disorder, Anti-cyclic citrullinated peptide antibody positive, Blood cholesterol increased, Dry mouth, Glossodynia, Lung disorder, Blister, Decreased appetite, General physical health deterioration, Vomiting, Migraine, Abdominal pain upper, Rash, Diarrhoea, Abdominal discomfort, Contraindicated product administered, Product quality issue, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, CANDESARTAN, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, OXYCODONE, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, RAMIPRIL, RAMIPRIL, RAMIPRIL, RITUXIMAB, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOPIRAMATE, TOPIRAMATE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, DICLOFENAC SODIUM, TOFACITINIB, LISINOPRIL, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, FISH OIL, |
||||
| 4271 | 24947555 |
US |
2 | |
Hidradenitis, Paraesthesia, Injection site reaction, Insurance issue, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 4272 | 24947767 |
CA |
70 | 2 |
Breast pain, Anxiety, Blood pressure increased, Communication disorder, Stress, Headache, Medication overuse headache, Pain, Paraesthesia, Rubber sensitivity, Contraindicated product administered, Drug ineffective, Drug ineffective for unapproved indication, Off label use, |
||||
ERENUMAB-AOOE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, MAGNESIUM, METOPROLOL TARTRATE, METOPROLOL, PROPRANOLOL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CALCIUM, ERGOCALCIFEROL, GABAPENTIN, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, ATORVASTATIN CALCIUM, NIFEDIPINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, FLUOXETINE HYDROCHLORIDE, RABEPRAZOLE, MIRTAZAPINE, SERTRALINE HYDROCHLORIDE, VALPROATE SODIUM, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
| 4273 | 24947930 |
GB |
59 | 1 |
Medication error, Paraesthesia, Pain in extremity, Fatigue, Influenza like illness, |
||||
ALIROCUMAB, OMALIZUMAB, |
||||
| 4274 | 24948004 |
GB |
85 | 2 |
Abdominal distension, Headache, Paraesthesia, |
||||
EZETIMIBE, AMLODIPINE, |
||||
| 4275 | 24948041 |
DE |
47 | 1 |
Paraesthesia, |
||||
EZETIMIBE, EZETIMIBE, |
||||
| 4276 | 24948300 |
US |
46 | 1 |
Paraesthesia, Feeling jittery, Agitation, Confusional state, Brain fog, Disturbance in attention, Condition aggravated, Feeling abnormal, Adulterated product, Product substitution issue, Hyperhidrosis, Product label issue, Therapeutic response decreased, Product substitution issue, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 4277 | 24948598 |
GB |
53 | 2 |
Hypoaesthesia oral, Anal hypoaesthesia, Paraesthesia oral, Paraesthesia, Tongue coated, Immobile, Vision blurred, Hypoaesthesia, Medication error, |
||||
| 4278 | 24948827 |
US |
2 | |
Renal injury, Multiple sclerosis relapse, Autoimmune thyroiditis, Postmenopausal haemorrhage, Lethargy, Pancreatic cyst, Fatigue, Eye disorder, Diarrhoea, Glomerular filtration rate abnormal, Central nervous system lesion, Paraesthesia, Burning sensation, Rash, Weight increased, Alopecia, |
||||
FINGOLIMOD HCL, |
||||
| 4279 | 24948856 |
US |
56 | 2 |
Post transplant lymphoproliferative disorder, Biliary tract disorder, Biloma, Abscess, Hepatic artery stenosis, Tremor, Paraesthesia, |
||||
CYCLOSPORINE, CYCLOSPORINE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, BASILIXIMAB, |
||||
| 4280 | 24949005 |
CA |
44 | 2 |
Autoimmune disorder, Breast cancer stage II, Adjustment disorder with depressed mood, Amnesia, Crohn^s disease, Disability, Deep vein thrombosis postoperative, Facet joint syndrome, Folliculitis, Gait disturbance, Hepatic cirrhosis, Hypercholesterolaemia, Irritable bowel syndrome, Lupus vulgaris, Lupus-like syndrome, Memory impairment, Migraine, Peripheral venous disease, Pneumonia, Pustular psoriasis, Road traffic accident, Thrombocytopenia, Pulmonary fibrosis, Sleep disorder due to general medical condition, insomnia type, Myositis, Lower limb fracture, Gastrointestinal disorder, Exostosis, Anti-cyclic citrullinated peptide antibody, Anxiety, Arthritis, Asthma, Back disorder, Bone erosion, Bursitis, C-reactive protein, Chest pain, Colitis ulcerative, Confusional state, Contusion, Dry mouth, Dyspepsia, Dyspnoea, Feeling hot, Fluid retention, Frequent bowel movements, Gait inability, Gastrointestinal disorder, General symptom, Grip strength decreased, Ill-defined disorder, Impaired healing, Infection, Inflammation, Insomnia, Joint stiffness, Laryngitis, Lip dry, Liver disorder, Lower respiratory tract infection, Lung disorder, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Myositis, Nasopharyngitis, Night sweats, Pain in extremity, Paraesthesia, Peripheral swelling, Porphyria acute, Pruritus, Psoriasis, Pyrexia, Rash vesicular, Red blood cell sedimentation rate increased, Sleep disorder, Stomatitis, Subcutaneous drug absorption impaired, Urticaria, Weight decreased, Weight increased, Wound infection, X-ray abnormal, Underdose, Therapy non-responder, Prescribed underdose, Incorrect route of product administration, |
||||
SARILUMAB, |
||||
| 4281 | 24949846 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Depression, Diarrhoea, Discomfort, Drug ineffective, Dry mouth, Duodenal ulcer perforation, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Maternal exposure during pregnancy, Memory impairment, Muscle injury, Migraine, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Off label use, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Product use in unapproved indication, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Drug intolerance, Epilepsy, |
||||
TOCILIZUMAB, RITUXIMAB, RITUXIMAB, LORAZEPAM, CALCIUM, CYANOCOBALAMIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, SULFASALAZINE, FISH OIL, |
||||
| 4282 | 24949853 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Contraindicated product administered, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Exposure during pregnancy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Off label use, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Product use in unapproved indication, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Folliculitis, Wound infection, Helicobacter infection, Incorrect route of product administration, Incorrect product administration duration, Medication error, Oedema, Ulcer haemorrhage, Swollen joint count increased, Weight decreased, Overdose, Osteoporosis, Oedema peripheral, Prescribed underdose, Rheumatic fever, Therapy non-responder, Treatment failure, |
||||
SARILUMAB, |
||||
| 4283 | 24950186 |
DE |
35 | 2 |
Arachnoiditis, Hypotonic urinary bladder, Hydrocephalus, Disability, Neurogenic bladder, Pain, Anal incontinence, Anal sphincter atony, Spinal pain, Hypoaesthesia, Monoparesis, Headache, Neck pain, Gait disturbance, Paraesthesia, Cyst, Intestinal atony, Muscle spasticity, Muscle twitching, Pain, Maternal exposure during pregnancy, Dizziness, |
||||
ROPIVACAINE HYDROCHLORIDE, |
||||
| 4284 | 24950200 |
GB |
2 | |
Dizziness, Headache, Bone pain, Myalgia, Fatigue, Muscle tightness, Nausea, Pain, Pruritus, Paraesthesia, Dysgeusia, Fall, Balance disorder, Brain fog, Raynaud^s phenomenon, |
||||
GADOTERATE MEGLUMINE, |
||||
| 4285 | 24950305 |
US |
1 | |
Hypoaesthesia, Hypoaesthesia, Paraesthesia, |
||||
FINASTERIDE, |
||||
| 4286 | 24951008 |
IT |
17 | 1 |
Neurotoxicity, Paraesthesia, Off label use, |
||||
VINCRISTINE SULFATE, VINCRISTINE SULFATE, |
||||
| 4287 | 24951371 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Contraindicated product administered, Decreased appetite, Depression, Diarrhoea, Dizziness, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Hypocholesterolaemia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, |
||||
| 4288 | 24951413 |
GB |
2 | |
Arthralgia, Headache, Paraesthesia, Oropharyngeal pain, Fatigue, Pain in extremity, |
||||
| 4289 | 24951521 |
US |
21 | 2 |
Confusional state, Electric shock sensation, Paraesthesia, Drug withdrawal syndrome, Dizziness, Tremor, |
||||
LUMATEPERONE, LUMATEPERONE, |
||||
| 4290 | 24951594 |
US |
47 | 2 |
Hypoaesthesia, Paraesthesia, Muscular weakness, Migraine, Photophobia, Hyperacusis, Nausea, Vomiting, |
||||
LUMATEPERONE, LUMATEPERONE, LUMATEPERONE, QUETIAPINE, QUETIAPINE, FLUOXETINE HYDROCHLORIDE, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE DIMESYLATE, CLONIDINE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, MAGNESIUM, CALCIUM, |
||||
| 4291 | 24951718 |
US |
65 | 2 |
Paraesthesia, Amnesia, Decreased appetite, Headache, |
||||
ABROCITINIB, |
||||
| 4292 | 24952255 |
DE |
||
Paraesthesia, Sensory disturbance, Nausea, Dizziness, |
||||
DIFELIKEFALIN, |
||||
| 4293 | 24952654 |
US |
55 | 1 |
Hypoaesthesia, Paraesthesia, Muscle enzyme abnormal, Muscular weakness, Gait disturbance, Fatigue, |
||||
BARICITINIB, BARICITINIB, |
||||
| 4294 | 24955363 |
69 | 2 | |
Dyspnoea, Paraesthesia, Chest discomfort, Fatigue, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, ERGOCALCIFEROL, |
||||
| 4295 | 24955476 |
51 | 2 | |
Injection site reaction, Paraesthesia oral, Paraesthesia, Dizziness, Anxiety, Therapy non-responder, Dyspepsia, Fatigue, Malaise, Product substitution issue, |
||||
TIRZEPATIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 4296 | 24945506 |
US |
1 | |
Hypoaesthesia, Paraesthesia, Drug ineffective, |
||||
EPLONTERSEN, |
||||
| 4297 | 24952101 |
40 | 1 | |
Headache, Refusal of treatment by patient, Peripheral coldness, Paraesthesia, Ocular hyperaemia, Weight decreased, Abnormal faeces, Varicocele, Product communication issue, Spermatic cord pain, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 4298 | 24944734 |
US |
1 | |
Paraesthesia, |
||||
EPLONTERSEN, |
||||
| 4299 | 24945158 |
US |
62 | 2 |
Hypoaesthesia, Paraesthesia, Pain in extremity, |
||||
CABOTEGRAVIR, |
||||
| 4300 | 24939844 |
US |
57 | 2 |
Neuralgia, Paraesthesia, Pain, Groin pain, Anal hypoaesthesia, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30
